Correlation Between Body Mass Index and Lymph Node Metastasis in Papillary Thyroid Carcinoma: a Retrospective Clinical Study

Overview

Journal Gland Surg

Publisher AME Publishing Company

Specialty Endocrinology

Date 2024 Sep 16

PMID 39282039

Authors

Haoran Ding

Fazhan Xu

Wenxian Guan

Jianfeng Sang

Affiliations

Soon will be listed here.

Abstract

Background: Papillary thyroid carcinoma (PTC) is the most common malignant tumor of the thyroid gland, with lymph node metastasis significantly affecting patient prognosis. In recent years, body mass index (BMI) has garnered widespread attention as a potential factor influencing cancer development. This study aimed to explore the relationship between BMI and lymph node metastasis in patients with PTC, particularly focusing on the risk of metastasis in the lateral and central neck compartments.

Methods: This retrospective study comprised 993 patients who underwent surgical treatment and were pathologically confirmed to have PTC. Patient BMI data were collected, and their relationship with lymph node metastasis in the lateral and central neck compartments was analyzed. Logistic regression models were employed to analyze the correlation between BMI and lymph node metastasis.

Results: The study found a significant correlation between BMI and the risk of lateral neck lymph node metastasis in patients (P=0.008), along with a corresponding increase in extrathyroidal extension risk (P=0.02). While elevated BMI did not directly increase the risk of central compartment metastasis, a significant increase was observed in the number of central compartment lymph node metastases (P=0.009) and their proportion among the total central compartment lymph nodes (P=0.01) in patients with higher BMI. Additionally, multifocality, age, and gender were identified as risk factors for lateral neck lymph node metastasis, whereas Hashimoto's thyroiditis did not exhibit a similar impact.

Conclusions: This study highlights that higher BMI is an important risk factor for lateral neck lymph node metastasis in patients with PTC and may exacerbate the severity of central compartment lymph node metastasis. These findings underscore the importance of considering BMI in the management of thyroid cancer and provide data support for future prevention and intervention strategies.

References

Saad E, Michel R, Borahay M . Cholesterol and Immune Microenvironment: Path Towards Tumorigenesis. Curr Nutr Rep. 2024; 13(3):557-565. DOI: 10.1007/s13668-024-00542-y. View

Huang X, Han Y, Yang J, Bu L, Cheng X, Zha X . Sex-dependent impact of obesity on aggressiveness of papillary thyroid cancer. Hormones (Athens). 2023; 23(2):217-225. DOI: 10.1007/s42000-023-00517-8. View

AlBashtawi J, Al-Jaber H, Ahmed S, Al-Mansoori L . Impact of Obesity-Related Endoplasmic Reticulum Stress on Cancer and Associated Molecular Targets. Biomedicines. 2024; 12(4). PMC: 11047871. DOI: 10.3390/biomedicines12040793. View

Chiefari E, Mirabelli M, La Vignera S, Tanyolac S, Foti D, Aversa A . Insulin Resistance and Cancer: In Search for a Causal Link. Int J Mol Sci. 2021; 22(20). PMC: 8540232. DOI: 10.3390/ijms222011137. View

Shen S, Radhakrishnan S, Harrell J, Puchalapalli M, Koblinski J, Clevenger C . The Human Intermediate Prolactin Receptor I-tail Contributes Breast Oncogenesis by Targeting Ras/MAPK Pathway. Endocrinology. 2024; 165(6). PMC: 11492283. DOI: 10.1210/endocr/bqae039. View

Iyengar N, Gucalp A, Dannenberg A, Hudis C . Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. J Clin Oncol. 2016; 34(35):4270-4276. PMC: 5562428. DOI: 10.1200/JCO.2016.67.4283. View

Ben Thayer M, Khanchel F, Helal I, Chiboub D, Raoueh H, Brahim E . Epidemiological and histopathological characteristics of thyroid carcinoma in a Tunisian health care center. World J Otorhinolaryngol Head Neck Surg. 2024; 10(1):37-42. PMC: 10979045. DOI: 10.1002/wjo2.147. View

Gambardella C, Offi C, Patrone R, Clarizia G, Mauriello C, Tartaglia E . Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?. BMC Endocr Disord. 2019; 19(Suppl 1):45. PMC: 6541563. DOI: 10.1186/s12902-019-0367-2. View

Dikaiou P, Edqvist J, Lagergren J, Adiels M, Bjorck L, Rosengren A . Body mass index and risk of cancer in young women. Sci Rep. 2024; 14(1):6245. PMC: 10940279. DOI: 10.1038/s41598-024-56899-1. View

10.

Wu W, Feng J, Ye J, Qi G, Hong L, Hu J . Influence of Obesity Parameters on Different Regional Patterns of Lymph Node Metastasis in Papillary Thyroid Cancer. Int J Endocrinol. 2022; 2022:3797955. PMC: 9663220. DOI: 10.1155/2022/3797955. View

11.

He J, Wei X, Li S, Liu Y, Hu H, Li Z . Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression. Cell Commun Signal. 2018; 16(1):100. PMC: 6299564. DOI: 10.1186/s12964-018-0309-z. View

12.

Alqaryan S, Almousa H, Almutairi R, Altuwaijri A, Doubi A, Alqahtani Z . Papillary thyroid microcarcinoma with and without nodal metastasis: A comparative analysis. Saudi Med J. 2024; 45(3):267-272. PMC: 11115404. DOI: 10.15537/smj.2024.45.3.20230638. View

13.

Thrift A, Kanwal F, Lim H, Duong H, Liu Y, Singal A . PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk. Clin Gastroenterol Hepatol. 2024; 22(9):1858-1866.e4. PMC: 11615715. DOI: 10.1016/j.cgh.2024.04.006. View

14.

Jafari F, Akerdi A, Abdolrahimzadeh Fard H, Karajizadeh M, Paydar S . Intraluminal extension of papillary thyroid carcinoma into the Internal Jugular Vein; a case report. BMC Endocr Disord. 2024; 24(1):49. PMC: 11036620. DOI: 10.1186/s12902-024-01580-x. View

15.

Kim M, Kang Y, Park Y, Koo B, Ku E, Choi J . Potential impact of obesity on the aggressiveness of low- to intermediate-risk papillary thyroid carcinoma: results from a MASTER cohort study. Endocrine. 2023; 82(1):134-142. DOI: 10.1007/s12020-023-03416-5. View

16.

Lam A . Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification. Methods Mol Biol. 2022; 2534:1-15. DOI: 10.1007/978-1-0716-2505-7_1. View

17.

Franchini F, Palatucci G, Colao A, Ungaro P, Macchia P, Nettore I . Obesity and Thyroid Cancer Risk: An Update. Int J Environ Res Public Health. 2022; 19(3). PMC: 8834607. DOI: 10.3390/ijerph19031116. View

18.

Zeng J, Deng J, He C, Xiong Q, Li X, Wang Z . IGF-1 Induces Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells by Promoting SOX4 via the MAPK/ERK Pathway. Int J Stem Cells. 2024; 17(4):418-426. PMC: 11612223. DOI: 10.15283/ijsc23165. View

19.

Zhao R, Lu Y, Wan Z, Qiao P, Yang L, Zhang Y . Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer. Aging (Albany NY). 2024; 16(8):7405-7425. PMC: 11087102. DOI: 10.18632/aging.205766. View

20.

Matrone A, Ceccarini G, Beghini M, Ferrari F, Gambale C, DAqui M . Potential Impact of BMI on the Aggressiveness of Presentation and Clinical Outcome of Differentiated Thyroid Cancer. J Clin Endocrinol Metab. 2019; 105(4). DOI: 10.1210/clinem/dgz312. View